J. Arbuthnott

发表

Proceedings of the 14th Symposium on Bacterial Toxins-International Session

J. Porath, H. Nikaido, N. Grecz, 1967 .

Enterotoxin production by Staphylococcus aureus isolates from cases of septicaemia and from healthy carriers.

D. Coleman, H. Humphreys, R. Hone, 1989, Journal of Medical Microbiology.

Physical States of Staphylococcal α-Toxin

J. Freer, A. W. Bernheimer, J. Arbuthnott, 1967 .

a-Toxin with Artificial and Natural Membranes1

J. Freer, A. W. Bernheimer, J. Arbuthnott, 2022 .

Qualitative and quantitative methods for detecting staphylococcal epidermolytic toxin.

J. Arbuthnott, B. Billcliffe, 1976, Journal of medical microbiology.

A toxic shock syndrome toxin mutant of Staphylococcus aureus isolated by allelic replacement lacks virulence in a rabbit uterine model.

T. Foster, R. Novick, B. Kreiswirth, 1991, FEMS microbiology letters.

TOXIC EPIDERMAL NECROLYSIS PRODUCED BY AN EXTRACELLULAR PRODUCT OF STAPHYLOCOCCUS AUREUS

C. Gemmell, J. Arbuthnott, J. Kent, 1971, The British journal of dermatology.

Staphylococcal toxins in human disease.

D. Coleman, J. Arbuthnott, J. D. de Azavedo, 1990, Society for Applied Bacteriology symposium series.

The challenge of cancer control in Africa

D. Kerr, P. Boyle, T. Ngoma, 2008, Nature Reviews. Cancer.

Experimental staphylococcal infections in newborn mice: inhibition of weight gain as an index of virulence.

O. Kinsman, J. Arbuthnott, 1980, Journal of medical microbiology.

Induction of tumour necrosis factor by staphylococcal toxic shock toxin 1.

J. Alouf, M. Parant, C. Jupin, 1988, FEMS microbiology immunology.

Molecular typing of methicillin and gentamicin resistantStaphylococcus aureus in Dublin

M. Mulvey, D. Coleman, J. Arbuthnott, 1986, European Journal of Clinical Microbiology.

Immunologically cross-reacting derivatives of Pseudomonas exotoxin A

J. Arbuthnott, K. Coleman, 1980 .

Haemagglutinating activity of Campylobacter pylori

N. Kennedy, P. Keeling, C. Smyth, 1988 .

Partial characterisation of Escherichia coli haemolysin.

R. Rennie, J. Arbuthnott, 1974, Journal of medical microbiology.

The kinetics of erythrocyte lysis by Escherichia coli haemolysin.

R. Rennie, J. Freer, J. Arbuthnott, 1974, Journal of medical microbiology.

Host damage from bacterial toxins

J. Arbuthnott, 1983 .

The action of streptolysin S on mouse-liver mitochondria.

J. Arbuthnott, D. A. Symington, 1973, Journal of medical microbiology.

Staphylococcal enterotoxins and the immune system.

I. Todd, A. Cockayne, J. Arbuthnott, 1991, FEMS microbiology immunology.

A new methicillin- and gentamicin-resistant Staphylococcus aureus in Dublin: molecular genetic analysis.

D. Coleman, C. Keane, H. Pomeroy, 1989, Journal of medical microbiology.

A new methicillin-and gentamicin-resistant Staphy / ococcus aureus in Dublin : molecular genetic

Russell, Carroll, Keane, 2022 .

Bacterial cytolysins (membrane-damaging toxins)

J. Arbuthnott, 1982 .

Damaging effect of toxic shock syndrome toxin 1 on chick embryo cells in vitro.

J. D. de Azavedo, J. Arbuthnott, A. Drumm, 1989, Reviews of infectious diseases.

Lipid-induced polymerization of staphylococcal -toxin.

J. Freer, J. Arbuthnott, B. Billcliffe, 1973, Journal of general microbiology.

Multiple forms of staphylococcal alpha-toxin.

P. Owen, J. Arbuthnott, A. McNiven, 1972, Journal of medical microbiology.

Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model

M. O'Reilly, T. Foster, R. Novick, 1985, Infection and immunity.

S. Mckay, J. Arbuthnott, 1979, Journal of medical microbiology.

Effect immunization with highly purified alpha- and beta-toxins on staphylococcal mastitis in rabbits

C. Adlam, A. C. Mccartney, J. Arbuthnott, 1977, Infection and immunity.

Effects of staphylococcal products on locomotion and chemotaxis of human blood neutrophils and monocytes.

R. Russell, P. Wilkinson, S. Mckay, 1976, Journal of medical microbiology.

Interaction of Staphylococcal α-Toxin with Artificial and Natural Membranes

J. Freer, A. W. Bernheimer, J. Arbuthnott, 1968 .

A comparative study of two serotypes of epidermolytic toxin from Staphylococcus aureus.

C. Bailey, J. D. de Azavedo, J. Arbuthnott, 1980, Biochimica et biophysica acta.

Interaction of Clostridium perfringens theta-haemolysin, a contaminant of commercial phospholipase C, with erythrocyte ghost membranes and lipid dispersions. A morphological study.

C. Smyth, J. Freer, J. Arbuthnott, 1975, Biochimica et biophysica acta.

Purification of staphylococcus alpha‐toxin

J. Arbuthnott, J. B. Spence, I. Lominski, 1963 .

A histopathological study of the effects of highly purified staphlococcal alpha and beta toxins on the lactating mammary gland and skin of the rabbit.

C. Adlam, A. C. Mccartney, J. Arbuthnott, 1979, Journal of comparative pathology.

Stimulation of rat spleen cells by staphylococcal enterotoxins.

I. Todd, H. Tranter, M. Holbrook, 1993, FEMS immunology and medical microbiology.

Isoelectric focusing studies of staphylococcal epidermolytic toxin

J. Arbuthnott, B. Billcliffe, W. D. Thompson, 1974, FEBS letters.

Cell envelope proteins of Staphylococcus epidermidis grown in vivo in a peritoneal chamber implant

R. Finch, S. Denyer, P. Williams, 1992, Infection and immunity.

Mechanisms of pathogenicity of multi-resistant Staphylococcus aureus.

M. Mulvey, T. Foster, D. Coleman, 1986, The Journal of hospital infection.

Properties of Clostridium perfringens (welchii) type-A alpha-toxin (phospholipase C) purified by electrofocusing.

C. Smyth, J. Arbuthnott, 1974, Journal of medical microbiology.

International Congress and Symposium Series

J. Arbuthnott, S. Shawcross, B. Furman, 1998 .

Identification of antigenic sites on staphylococcal enterotoxin B and toxoid.

I. Todd, H. Tranter, J. Arbuthnott, 1997, FEMS immunology and medical microbiology.

Staphylococcal enterotpxins and the immune system

I. Todd, A. Cockayne, J. Arbuthnott, 1991 .

Toxins of Staphylococcus aureus.

J. Freer, J. Arbuthnott, 1982, Pharmacology & therapeutics.

A Staphylococcal Toxic Complex Affecting Particular Areas of the Mitochondrial Electron Transport System

C. Gemmell, J. Arbuthnott, I. Lominski, 1968 .

IMPAIRMENT OF SUCCINIC OXIDASE OF MOUSE-LIVER MITOCHONDRIA BY A FACTOR PRODUCED BY STAPHYLOCOCCUS PYOGENES.

C. Gemmell, J. Arbuthnott, I. Lominski, 1964, Lancet.

Haemolysin and enzyme patterns of coagulase-positive staphylococci isolated from toxic epidermal necrolysis, Ritter's disease and impetigo contagiosa.

C. Gemmell, J. Arbuthnott, J. Kent, 1969, Journal of medical microbiology.

Investigation of microbial growth in vivo: evaluation of a novel in vivo chamber implant system.

A. Cockayne, E. Arbuthnott, J. Arbuthnott, 1992, FEMS microbiology letters.

A simple method for the study in vivo of bacterial growth and accompanying host response.

J. Arbuthnott, R. Russell, S. Day, 1980, The Journal of infection.

STUDIES OF STAPHYLOCOCCAL TOXINS IN RELATION TO TOXIC EPIDERMAL NECROLYSIS (THE SCALDED SKIN SYNDROME)

C. Gemmell, J. Arbuthnott, J. Kent, 1972 .

[46] Assays for epidermolytic toxin of Staphylococcus aureus

J. Arbuthnott, J. Azavedo, 1988 .

Plasmids in epidermolytic strains of Staphylococcus aureus.

G. Dougan, M. O'Reilly, T. Foster, 1981, Journal of general microbiology.

Cloning, and expression in Escherichia coli K-12, of the chromosomal hemolysin (phospholipase C) determinant of Pseudomonas aeruginosa

G. Dougan, J. Arbuthnott, K. Coleman, 1983, Journal of bacteriology.

Staphylococcus alpha toxin

J. Arbuthnott, 1964 .

Consequences of spingomyelin degradation in erythrocyte ghost membranes by staphylococcal beta-toxin (sphingomyelinase C).

D. Low, R. Möllby, J. Freer, 1974, Toxicon : official journal of the International Society on Toxinology.

Immunisation against experimental staphylococcal infection with coagulase-rich preparations.

D. Smith, D. Muir, J. Arbuthnott, 1962, Lancet.

Effect of toxic shock syndrome toxin 1 on chicken embryos

J. D. de Azavedo, J. Arbuthnott, R. Lucken, 1985, Infection and immunity.

Toxicity of staphylococcal toxic shock syndrome toxin 1 in rabbits

J. D. de Azavedo, J. Arbuthnott, J C de Azavedo, 1984, Infection and immunity.

Some characteristics of Staphylococcus alpha haemolysin.

J. Arbuthnott, I. Lominski, 1962, The Journal of pathology and bacteriology.

The challenge of cancer control in Africa

D. Kerr, P. Boyle, T. Ngoma, 2008, Nature Reviews Cancer.

Characterization of staphylococcal gamma-lysin.

T. Birkbeck, J. Arbuthnott, M. Clyne, 1992, Journal of general microbiology.

Development and design of a novel in vivo chamber implant for the analysis of microbial virulence and assessment of antimicrobial therapy.

R. Slack, A. Cockayne, J. Arbuthnott, 1991, Microbial pathogenesis.

EFFECT OF STAPHYLOCOCCUS ALPHA-TOXIN ON SOME COLD-BLOODED ANIMALS.

C. Gemmell, J. Arbuthnott, I. Lominski, 1965, The Journal of Pathology and Bacteriology.

Staphylococcus aureus bacteriophages mediating the simultaneous lysogenic conversion of beta-lysin, staphylokinase and enterotoxin A: molecular mechanism of triple conversion.

D. Coleman, D. Sullivan, H. Pomeroy, 1989, Journal of general microbiology.

Cloning and expression in Escherichia coli and Staphylococcus aureus of the beta-lysin determinant from Staphylococcus aureus: evidence that bacteriophage conversion of beta-lysin activity is caused by insertional inactivation of the beta-lysin determinant.

D. Coleman, T. Birkbeck, H. Pomeroy, 1986, Microbial pathogenesis.

Properties of Escherichia coli grown in vivo using a chamber implant system.

G. Dougan, J. Arbuthnott, T. Finn, 1982, Journal of general microbiology.

Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome

E. Carlson, J. D. de Azavedo, J. Arbuthnott, 1988, Journal of clinical microbiology.

Colonial dissociation and susceptibility to phagocytosis of Pseudomonas aeruginosa grown in a chamber implant model in mice

R. Hancock, N. Kelly, S. Kuo, 1987, Infection and immunity.

Pathogenesis of skin and wound infections. Animal models

O. Kinsman, J. Arbuthnott, 1990 .

Physical states of staphylococcal alpha-toxin.

J. Freer, A. W. Bernheimer, J. Arbuthnott, 1967, Journal of bacteriology.

Foodborne illness: an overview

W. Waites, J. Arbuthnott, 1990, The Lancet.

Some properties of IgG1 and IgG2 globulins from normal and adjuvant stimulated guinea-pigs.

J. Freer, D. Stewart-Tull, J. Arbuthnott, 1975, Immunochemistry.

The oxygen metabolism of microorganisms: By D. E. F. HARRISON. 1976. Patterns of progress (microbiology) series. Shildon, Co. Durham: Meadowfield Press Ltd. Pp. 69. £2.80.

J. Arbuthnott, 1978 .

Molecular cloning and genetic analysis of the determinant for gamma-lysin, a two-component toxin of Staphylococcus aureus.

M. Mulvey, T. Foster, J. Arbuthnott, 1988, Journal of general microbiology.

Action of staphylococcal epidermolytic toxin on mouse skin: an electron microscopic study.

J. Arbuthnott, A. Lyell, A. Mclay, 1975, The Journal of investigative dermatology.

Author index-volume 46

G. Radda, B. Haye, A. McLaughlin, 1985, Steroids.

Inhibition of staphylococcal alpha-toxin. A kinetic evaluation of aromatic polysulphonic acids as inhibitors of haemolysis.

M. R. Wright, J. Arbuthnott, I. Lominski, 1968, The Biochemical journal.

Anatomy of a Merger

J. Arbuthnott, T. Bone, 1993 .

[5] Purification of epidermolytic toxin of Staphylococcus aureus

C. Bailey, J. Arbuthnott, J. Azavedo, 1988 .

Role of exotoxins in bacterial pathogenicity.

J. Arbuthnott, 1978, The Journal of applied bacteriology.

Physical States of Staphylococcal Alpha Toxin1 (Abstract)

J. Freer, A. W. Bernheimer, J. Arbuthnott, 1967 .

Interaction of staphylococcal alpha-toxin with artificial and natural membranes.

J. Freer, A. W. Bernheimer, J. Arbuthnott, 1968, Journal of bacteriology.

Staphylococci associated with toxic shock syndrome in the United Kingdom.

A. Wieneke, J. Arbuthnott, M. De Saxe, 1982, Annals of Internal Medicine.

Prevalence of epidermolytic toxin in clinical isolates of Staphylococcus aureus.

J. Arbuthnott, J. D. Azavedo, 1981, Journal of medical microbiology.

Toxic shock syndrome in Britain.

A. Wieneke, J. Arbuthnott, M. De Saxe, 1982, British medical journal.

Effects of staphylococcal -toxin on the structure of erythrocyte membranes: a biochemical and freeze-etching study.

J. Freer, J. Arbuthnott, B. Billcliffe, 1973, Journal of general microbiology.

The response of hairless mice to staphylococcal epidermolytic toxin

J. Arbuthnott, W. Noble, J. Kent, 1973, The British journal of dermatology.

Cell-associated alpha-toxin from Staphylococcus aureus.

J. Arbuthnott, A. McNiven, 1972, Journal of medical microbiology.

THE KINETICS OF ERYTHROCYTE LYSIS BY

R. Rennie, J. Freer, J. Arbuthnott, 1974 .

Effect of Carbohydrates on Hemolysin Production by Escherichia coli

R. Rennie, J. Arbuthnott, 1971, Infection and immunity.

Effects of staphylococcus alpha-toxin and streptolysin S on the oxidation of succinate by ascites tumour cells.

J. Arbuthnott, D. A. Symington, 1969, Journal of medical microbiology.

Cholesterol esterase activity in the culture supernatant of Staphylococcus aureus NCTC 7121

G. Beastall, A. C. Mccartney, J. Arbuthnott, 1977 .

Effect of staphylococcal alphatoxin on striated muscle of mice.

J. Arbuthnott, I. Lominski, A. Scott, 1962, Lancet.

Physical properties of staphylococcal alpha-toxin and aspects of alpha-toxin membrane interactions.

J. Freer, J. Arbuthnott, A. McNiven, 1973, Contributions to microbiology and immunology.

The challenge of cancer control in Africa

D. Kerr, P. Boyle, T. Ngoma, 2008, Nature Reviews Cancer.

The inhibition of cartilage matrix production by glutamylaminoacetonitrile in vitro.

J. Arbuthnott, H. M. McCallum, 1969, Experimental and molecular pathology.